AUCTORES
Globalize your Research
Case Report | DOI: https://doi.org/10.31579/2640-1053/144
1 Head of Cardio-Oncology Department Roffo Institute. Buenos Aires. Argentina.
2 Sub Chief Heart Transplant, Heart Failure and Pulmonary Hypertension Sagrado Corazón. Buenos Aires. Argentina.
*Corresponding Author: Andrés J. Daniele, Head of Cardio-Oncology Department Roffo Institute. Buenos Aires. Argentina
Citation: Andrés J. Daniele, Vanesa Gregorietti, (2023). Cardiotoxicity Memory, Cardio-oncology Risk & Predisposing Genetic ¿Who is the Real Evil?, J. Cancer Research and Cellular Therapeutics. 7(2); DOI:10.31579/2640-1053/144
Copyright: © 2023, Andrés J. Daniele. this is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 03 May 2023 | Accepted: 02 June 2023 | Published: 20 June 2023
Keywords: cardiotoxicity, cardiotoxicity memory, cardio-oncology risk, permissive cardiotoxicity
For several decades, medicine has tried to establish the risk of people developing cardiovascular disease. (1,2)
Different research groups developed and validated different scores for the assessment of cardiovascular risk in the population. (3,4)
In their development, assessment of cancer patients was not included, and the oncology history or treatments received were not considered. (3,4)
When we use them in daily to evaluate cancer patients in clinical practice, are we making a mistake?
On the other hand, when the cardiovascular assessment of cancer patients is carried out, do we consider the consecutive or simultaneous oncological therapies that the patient receives to define the risk of a cardiovascular adverse event?
We have a challenge, and we're going to try to cla
Case 1
A 32-year-old female patient. He has a pathological history of non-Hodgkin lymphoma when she was 16 years old, so she was treated with RCHOP for 6 cycles and radiotherapy
9 months ago, she was diagnosed with left breast Cancer HER2 + HR - Ki67 70% in stage III. Neoadjuvant was performed with Trastuzumab followed by mastectomy and axillary nodal emptying.
Prior to the neoadjuvant therapy, a cardiovascular evaluation was conducted where it was found that the patient did not present cardiovascular risk factors, so she presented a SCORE 2 <1>
After surgery, adjuvant therapy with double anti-HER2 blockade (Trastuzumab and Pertuzumab) associated with Docetaxel was indicated.
Before the third cycle, the patient reported presenting dyspnea NYHA CF II-III, so she was referred to the cardio-oncology department where clinical signs of global heart failure were observed.
A new echocardiogram was performed that showed a drop in LVEF to a value of 32% with a GLS – 11.
Case 2
A 42-year-old male patient without history of risk factors or cardiovascular disease. SCORE 2 < 1>
Diagnosis of chronic myeloid leukemia at 37 years old. Treated with Imatinib, Dasatinib, and Nilotinib sequentially due to lack of therapeutic response
During treatment with Nilotinib, an ultrasound of arteries of the lower limbs was performed, which showed the presence of atherosclerotic lesions in the right superficial femoral artery that caused a 20% obstruction.
Due to treatment failure with nilotinib, the patient was reassessed and tested for the T315i mutation whose was positive, so treatment with Ponatinib 45 mg per day was indicated.
Six months after starting Ponatinib, the patient attends the consultation for intermittent claudication of the right lower limb at 50 meters,
A new ultrasound of arteries of the lower limbs is performed, verifying the evolution of the lesion of the right superficial femoral artery that now generates an obstruction of 85%.
Case 3
A 43-year-old patient who consults for the progressive deterioration of functional degree after mild influenza three months before the consultation. As relevant background Hodking Lymphoma treated at age 19 with ABVD. LVEF 6 months after finishing treatment was 50%
He goes to consult with dyspnea of minimal efforts and bilateral edemas up to the root of limbs. The ECG shows sinus rhythm with left bundle branch block.
The echo shows LVEF 25%. Depletive treatment is initiated and with Sacubitril/ Valsartan, Beta blockers, eplerenone and SLGT2i. Coronary angiography is requested showing absence of significant coronary heart disease and a Magnetic Resonance. That rule out the diagnosis of myocarditis
The patient evolves favorably with improvement of LVEF up to 48% at 6 months of treatment
Cardiology was originally limited to describing cardiovascular adverse events after cancer therapy.
Then, only patients in cancer remission who evolved with advanced stages of heart failure were treated and assessed for a heart transplant.
Since the advent of anthracyclines and the first descriptions of cardiac involvement secondary to them we have advanced in the study of the various predisposing factors of the occurrence of different types of cardiotoxicities. [1,2,3]
For many years we tried to predict the probability of the presentation of a cardiotoxic events through the assessment of the cardiovascular risk of our patients using cardiovascular risk scores developed for the general population. [3,4]
Clinical experience has shown us that, although with them, we have achieved an approach in the prediction of cardiovascular adverse events in cancer patients, but they are not effective enough to measure the certain probability of their occurrence.
Based on this finding, different groups began to study and publish risk scores that incorporated factors related to the patient's cancer history and their treatment. [5]
Some of these scores have been validated, demonstrating the highest precision in the prediction of the occurrence of cardiovascular adverse events secondary to cancer therapies. [6,7]
For this reason, we are tempted to suggest that when we talk about risk assessment for our cancer patients, we are no longer talking about cardiovascular risk.
We must use the term of cardio-oncology risk, since it would be more comprehensive, and it would conceptualize the basis of our specialty where the patient is the center of a multidisciplinary approach and the abode of different morbidities coexistence.
In addition, for several years, the scientific community has been studying the pathophysiology of cardiac toxicities and the biomolecular mechanisms associated with them. [8,9]
It has been possible to elucidate some of the mechanisms underlying cardiovascular adverse events secondary to certain drug groups, whereas with others we have only speculated. [10]
In this uncertain situation, clinical practice has shown that the implementation of successive cancer therapies predisposes patients to have a higher incidence of cardiovascular adverse events. [7,11]
And is it possible that when our patient is treated with specific cancer therapy, they create an indelible imprint on their cardiovascular system?
Our conviction, based on the demonstration of numerous studies on the increase in the incidence of cardiotoxicities with the achievement of consecutive specific cancer therapies, is that each therapy generates that footprint in the cardiovascular system and therefore we have coined the term cardiotoxicity memory.
Cardiotoxic memory presents us with the challenge of minimizing, through cardioprotective treatments, the impact that oncology therapies have on our patients.
But we have another question. Does this imprint have any relation to the presence of certain predisposing genes in the DNA?
In recent days, Purmina Singh et al. published the relationship between the haptoglobin gene and anthracycline-related cardiomyopathy. [12,13]
In addition, Wang et al. describe the association between CELF4 and GSMT1 and anthracycline-related cardiomyopathy. [13, 14,15]
It is valid to think that the presence of certain genes predisposes a patient to present a greater susceptibility to presenting vascular endothelial dysfunction secondary to cancer therapy and thus increasing the probability that a consecutive treatment increases the possibility of the occurrence of a cardiovascular adverse event.
Otherwise, in a context where therapies are increasingly effective in achieving remission or "chronicity" of oncological pathology; we must consider what is, in the event of cardiotoxicity, the precise indication to limit them.
Understanding that suspending specific cancer treatments to determine our patient's prognosis is that we need to open to a new concept described recently: permissive cardiotoxicity. [16]
When we ask ourselves who the real devil is, we consider that the concept of cardiotoxic memory should be anchored in our day-to-day cardio-oncology practice, because the achievement of therapies for cancer, often despised in the baseline evaluation of approval of a new line of oncological treatment, is the basis of the cardio-oncology risk of our patients.
Therefore, we must increase our efforts to understand the pathophysiological basis by which the various drugs for cancer and, especially, their combination simultaneously or sequentially produce damage to the cardiovascular system.
Otherwise, based on the above, we can also conclude that the assessment of cardio-oncology risk and permissive cardiotoxicity are two tools that, in the context of an adequate baseline evaluation and rigorous monitoring at follow-up, will allow us to improve the oncological prognosis of our patients benefiting their accessibility to effective cancer therapies.
Cardio-oncology is a young and fertile field of research where we still have a long way to go to achieve a complete understanding how the patient´s cardiovascular system responding to different cancer therapies and how, through this, we can develop targeted prevention strategies; therefore, being able to apply precision medicine in our specialty.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
